| 产品详情 |
| Edit |   |
|---|
| Product Name | WM983A Purified RNA |
|---|
| Description | Total RNA was prepared from cell line WM983A. WM983A is a VGP human malignant metastatic melanoma cell line that features the V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line is wild type for PTEN, N-RAS, c-KIT, and CDK4. This cell line was derived from the same patient as the cell lines WM983B, WM983B BR and WM983C.WM983A cells produce xenograft tumors when injected into immunocompromised mice. |
|---|
| Size | 5 µg |
|---|
| Concentration | 200 ng / µl |
|---|
| Applications | Purified RNA is suitable for a number of molecular biology applications including but not limited to next generation sequencing and expression library construction, PCR, real-time PCR, microarray analysis, and transfection experiements. |
|---|
| Other Names | Human Melanoma, patient derived tumor, tumor models, skin cancer, xenograft |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | WM983A-04-0200 |
|---|
| Price | |
|---|
| Order / More Info | WM983A Purified RNA from ROCKLAND IMMUNOCHEMICALS INC. |
|---|
| Product Specific References | Szaboet al. Temporally designed treatment of melanoma cells by ATRA and polyI: C results in enhanced chemokine and IFNβ secretion controlled differently by TLR3 and MDA5. Melanoma Res. (2012) 22:351-61. doi: 10.1097/CMR.0b013e328357076c. |
|---|
| 产品资料 |
|
|